Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Clinical trial NCT06677060 · RECRUITING
Trial details
- NCT number
- NCT06677060
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-14
- Primary completion
- 2029-12-17
- Enrollment
- 11300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.